Home Healthcare

Healthcare

Impact focus – Solutions that remimagine access and affordability of healthcare

Sex tech was back at the annual Consumer Electronic Show, with the focus on more polite theme of “wellness,” and less on sex toys. The wellness technology goes beyond vibrators to tools intended to...
Drugmakers are finding themselves getting into mining these days. And venture capital is taking notice. Pharmaceutical companies have started to replace parts of clinical trials with mining medical records to speed drug approval, with...
Fracking, assailed for its environmental cost while its made the U.S. the world’s top oil producer, is being investigated as a possible cause in the surge of young people hit by a rare cancer in Pennsylvania.Pennsylvania is...
It’s the world’s most expensive drug, and one of only two available for spinal muscular atrophy, the top genetic killer of children under two years old. And now the drug’s maker, Novartis, wants to give it away...
It may be the final frontier in medicine -- slowing down or reversing the process of aging. Besides the promise of a longer life, it also means fortunes made -- think Ponce de Leon and his search...
Purdue Pharma, facing fines of $12 billion for fueling the opioid crisis in the U.S., has a foreign affiliate peddling a surprising medication -- an antidote for opioid overdose. And now the Australian affiliate...
Magic mushrooms as a treatment for depression took another step toward mainstream acceptance as a venture capital-backed company announced positive results from a psilocybin trial. Compass Pathways’ psilocybin medication was “well-tolerated in healthy volunteers,”...
Private equity and venture capital firms, which have poured billions of dollars in biotech firms, are opposing House Speaker Nancy Pelosi’s plan to cut drug prices, saying it would stifle the small firms that are often the...
Magic Leap, in the midst of a pivot after its much-hyped entertainment headset failed to catch on, debuted a new version of its augmented-reality equipment that’s designed for a new crowd -- businesses including healthcare.The Magic Leap...
Key Takeaway: Even though his research opens up a variety of ethical issues and has received funding from donors like sex offender Jeffrey Epstein, geneticist George Church...
Magnetar Capital, which has made billions on its energy and infrastructure bets, is joining others who are seeing green lights flashing in healthcare. The $13.4 billion hedge fund is seeking to raise $400 million,...
Amazon’s latest step in using technology to make healthcare more effective is simple: A voice-technology service that enables medical providers to spend more time with patients.The service, called Amazon Transcribe Medical, enables doctors to quickly dictate their...
A year after a Chinese scientist unleashed a storm of condemnation by announcing the birth of a baby whose genes he had edited, the medical and scientific community has yet to agree on rules guiding research into...
Stem cell biotech company Novoheart and pharmaceutical giant AstraZeneca announced they would be partnering to develop the first test tube model of human heart failure, also called heart-in-a-jar. The companies said they would use...
Mark Zuckerberg, Facebook’s embattled co-founder and CEO, isn’t just interested in creating the biggest ad machine and political platform in history. He also wants to fix and accelerate the rate of scientific discovery. In...
Blackstone, which last year started up a life sciences investing arm, is pouring $400 million into a venture with a Swiss pharmaceutical firm to develop and commercialize a gene therapy for bladder cancer. Blackstone’s...
A recent number of studies and funding rounds offered a glimpse into what the new wave of quantum biology research may offer and how the new generation of innovative solutions may take shape. Mursla,...
Medicare may not be getting the best prescription drug deals it can, meaning senior citizens using the plan are overpaying, a new study suggests. Private insurance companies adopt cheaper generic drugs at a faster...
Private equity firm GHO Capital Partners, reflecting European investors’ bullishness for healthcare, topped expectations by raising almost $1.1 billion for its second fund.  The total, surpassing GHO’s $885 million goal, is a record for...
Oxycontin maker Purdue Pharma cultivated sympathetic writers and funded think tanks as part of an aggressive media campaign aimed at countering negative stories about its blockbuster opioid, ProPublica reported. For nearly 20 years Purdue...
There’s no question that global warming is already affecting global health. As natural disasters displace millions of people, higher average temperatures encourage the spread of disease.  About 7 million people die annually from pollution exposure, says the...
It has been an exciting week for quantum biology enthusiasts, with two separate studies suggesting new ways to leverage quantum principles in life sciences applications. Researchers from the Quantum Nanophysics Group at the University...
KKR, which last month said profit slipped on costlier dealmaking, proposed buying Walgreens Boots Alliance as the private equity firm pushes deeper into healthcare.  The potential deal, reported by Bloomberg News based on unidentified...
A lawsuit filed by the Trump administration against Gilead Sciences is the most direct action taken to date to bring down the high cost of HIV prevention pills – a critical component of the government’s plan to...
The transplantation of pig organs into humans moved a step closer to reality after investors upped their bets, pouring in $100 million, on the work of biotechnology company eGenesis. The Cambridge, Massachusetts company uses...
This content is brought to you in partnership with HLTH. Last week, more than 6,000 attendees — from executives, investors and startups to policymakers, pharmaceutical companies and insurance providers — gathered at the MGM...
A controversial drug that treats the early stages of Alzheimer’s disease might become the first medication for the disease in 17 years to win regulatory approval. Biogen Inc. said it plans to submit a...
Key Takeaway: With concerns about the privacy of genetic data rising, Nebula Genomics has developed a Blockchain-based genomic marketplace, where users decide who gets access to their...
Amazon and JPMorgan Chase, working with Warren Buffett’s Berkshire Hathaway, are rolling out employee healthcare plans, the latest example of big tech making unlikely alliances in an effort to carve out territory in healthcare.
Google, scouting out opportunities at the intersection of digital technology and healthcare, is paying $2.1 billion to buy Fitbit, which will permit it to leverage its tech expertise and expand in the rapidly growing wearables market.
- Advertisement -
WP RSS Plugin on WordPress